Ushbu ish iqtibos qilgan ishlar

17 ta ish

Ish: Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

1. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

   Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

   MaqolaOAOchiq kirish201012 iqtibos

   ABIABI:AkademIndex/2026.other.027992

2. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

   Shama D. Ahuja, David Ashkin, Monika Avendano +70

   Sharh maqolaOAOchiq kirish20129 iqtibos

   ABIABI:AkademIndex/2026.other.027993

3. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

   Elisabeth Sánchez-Padilla, Caroline Marquer, Stobdan Kalon +5

   Maqola20145 iqtibos

   ABIABI:AkademIndex/2026.other.175880

4. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

   Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11

   Sharh maqolaOAOchiq kirish20124 iqtibos

   ABIABI:AkademIndex/2026.other.027990

5. Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

   Maryline Bonnet, Manuela Pardini, Francesca Meacci +14

   MaqolaOAOchiq kirish20114 iqtibos

   ABIABI:AkademIndex/2026.other.034179

6. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

   Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

   Sharh maqolaOAOchiq kirish20144 iqtibos

   ABIABI:AkademIndex/2026.other.034193

7. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

   Ekaterina V. Kurbatova, A. Taylor, Victoria M. Gammino +13

   MaqolaOAOchiq kirish20124 iqtibos

   ABIABI:AkademIndex/2026.other.175871

8. Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis

   Molly F. Franke, Mercedes C. Becerra, Dylan B. Tierney +5

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.027991

9. Emergence of Extensive Drug Resistance during Treatment for Multidrug-Resistant Tuberculosis

   Helen Cox, C Sibilia, Silke Feuerriegel +6

   BoshqaOAOchiq kirish20083 iqtibos

   ABIABI:AkademIndex/2026.other.175872

10. Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

    James C. Johnston, Neal Shahidi, Mohsen Sadatsafavi +1

    Sharh maqolaOAOchiq kirish20093 iqtibos

    ABIABI:AkademIndex/2026.other.175874

11. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

    Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi +16

    Sharh maqolaOAOchiq kirish20122 iqtibos

    ABIABI:AkademIndex/2026.other.027989

12. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

    Evan Orenstein, Sanjay Basu, N. Sarita Shah +5

    Sharh maqola20092 iqtibos

    ABIABI:AkademIndex/2026.other.175873

13. High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010

    Elisabeth Sánchez-Padilla, Themba Dlamini, Alexandra Ascorra +7

    MaqolaOAOchiq kirish20122 iqtibos

    ABIABI:AkademIndex/2026.other.175879

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.175875

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.175876

16. Sarlavhasiz

    BoshqaOAOchiq kirish1 iqtibos

    ABIABI:AkademIndex/2026.other.175877

17. Sarlavhasiz

    BoshqaOAOchiq kirish1 iqtibos

    ABIABI:AkademIndex/2026.other.175878